ArticleAmerican journal of translational research2026
Evaluation of the efficacy and safety of unilateral biportal endoscopic technique for the treatment of infectious spondylitis.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo compare the efficacy and safety of unilateral biportal endoscopic technique (UBE) and percutaneous endoscopic debridement, irrigation, and drainage for infectious spondylitis, and provide evidence for clinical decision-making.
methodsA retrospective study included 108 patients (February 2023-May 2024) divided into a biportal group (n=54, UBE) and single portal group (n=54, percutaneous endoscopic surgery). Surgery-related indicators, inflammatory markers (ESR (erythrocyte sedimentation rate), CRP (C-reactive protein), TNF-α (tumor necrosis factor-α)), VAS (visual analog scale), ODI (Oswestry disability index), Kirkaldy-Willis score, Cobb angle, and bacterial culture positive rate were compared. Multiple linear regression analyzed factors influencing postoperative 120-day ESR.
resultsThe biportal group had longer surgical duration, drainage time, and more fluoroscopy (all
conclusionsUBE and percutaneous endoscopic surgery have comparable efficacy in relieving pain, improving function, correcting deformity, and pathogen detection. UBE provides better long-term inflammatory control, and surgical choice should consider disease complexity, surgeon proficiency, and need for inflammatory control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.